Montelukast Prescribing at HOLDERNESS HEALTH
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
6,357
Total Quantity
178.0K
NHS Cost
£9.0K
vs National Avg
+828.4%
HOLDERNESS HEALTH prescribed 6,357 items of Montelukast over the last 12 months at a cost of £8,964 to the NHS. This is 828.4% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
478
Jul 2026
473
Jul 2026
590
Jul 2026
517
Jul 2026
528
Jul 2026
553
Jul 2026
581
Jul 2026
574
Jul 2026
542
Jul 2026
461
Jul 2026
543
Jul 2026
517
Prescribing Details
| Total Items | 6,357 |
|---|---|
| Total Quantity | 177,975 |
| Total NHS Cost | £8,964 |
| Presentations | 5 different forms |
| vs National Average | +828.4% |
Montelukast Prescribing Comparison
| This practice | 6,357 items |
|---|---|
| National average per practice | 685 items |
| Difference | +828.4% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.